Post-approval studies (Phase 4)WithdrawnNCT02760615What this trial is testingPhase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWho this might be right forColitis, UlcerativeCrohn Disease Takeda
Large-scale testing (Phase 3)Ended earlyNCT03467958What this trial is testingAn Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Celgene 854
Large-scale testing (Phase 3)Study completedNCT03945019What this trial is testingCT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)Who this might be right forCrohn's Disease Celltrion 396
Not applicableEnded earlyNCT00936585What this trial is testingNIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's DiseaseWho this might be right forColitisCrohn's DiseaseInflammatory Bowel Disease National Institutes of Health Clinical Center (CC) 2
Large-scale testing (Phase 3)UnknownNCT04919252What this trial is testingEfficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel DiseaseWho this might be right forCrohn's Disease and Ulcerative Colitis Yonsei University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06233461What this trial is testingA Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Takeda 268
Testing effectiveness (Phase 2)Looking for participantsNCT07078994What this trial is testingClinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's DiseaseWho this might be right forCrohn's Disease (CD) Biocad 204
Early research (Phase 1)Study completedNCT04254783What this trial is testingEvaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseWho this might be right forUlcerative Colitis (UC)Crohn's Disease AbbVie 20
Not applicableStudy completedNCT02846961What this trial is testingAnti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel DiseaseWho this might be right forInflammatory Bowel DiseaseUlcerative ColitisCrohn's Disease Kyungpook National University Hospital 280
Testing effectiveness (Phase 2)Ended earlyNCT01545050What this trial is testingDose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease CSL Behring 72
Post-approval studies (Phase 4)Study completedNCT02148718What this trial is testingRapidity of Response to Adalimumab Treatment in Patients With Crohn´s DiseaseWho this might be right forModerate to Severe Crohn's Disease AbbVie 100
Testing effectiveness (Phase 2)Study completedNCT04877990What this trial is testingEvaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisWho this might be right forCrohn DiseaseUlcerative Colitis Bristol-Myers Squibb 67
Testing effectiveness (Phase 2)Study completedNCT02389790What this trial is testingExtension Study of MT-1303 in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Tanabe Pharma Corporation 46
Very early researchNot Yet RecruitingNCT07309744What this trial is testingUniversal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel DiseaseWho this might be right forModerate-to-severe Ulcerative ColitisCrohn's Disease (CD) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Study completedNCT06309472What this trial is testingTrial of Mirtazapine for Depression in IBDWho this might be right forMajor Depressive DisorderInflammatory Bowel Diseases King's College London 76
Not applicableUnknownNCT05262829What this trial is testingClinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's DiseaseWho this might be right forCrohn Disease Shanghai East Hospital 40
Large-scale testing (Phase 3)Study completedNCT00105300What this trial is testingStudy of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseWho this might be right forCrohn's Disease Abbott 300
Large-scale testing (Phase 3)WithdrawnNCT05104229What this trial is testingSAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD SurgeryWho this might be right forCrohn DiseaseUlcerative ColitisVenous Thromboembolism Stefan Holubar MD MS FACS, FASCRS
Large-scale testing (Phase 3)Ended earlyNCT04173273What this trial is testingA Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Pfizer 379
Not applicableLooking for participantsNCT04528355What this trial is testingData Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RICWho this might be right forPrimary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more Paul Szabolcs 50